Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Cash Flow Quality Index

Latest as of September 2025: 2.41x

Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Cash Flow Quality Index of 2.41x as of September 2025. Operating cash flow of CN¥52.93 Million exceeds net income of CN¥21.95 Million, indicating high earnings quality where cash backs reported profits. Explore 300254 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

2.41x
Operating CF / Net Income

Operating Cash Flow

CN¥52.93 Million
CNY

Net Income

CN¥21.95 Million
CNY

Data as of

Sep 2025
Most recent filing

Shanxi C&Y Pharmaceutical Group Co Ltd Cash Flow Quality Index (2008–2025)

Historical Cash Flow Quality Index for Shanxi C&Y Pharmaceutical Group Co Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) cash conversion ratio.

Annual Cash Flow Quality Index for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)

Year-by-year earnings quality comparison for Shanxi C&Y Pharmaceutical Group Co Ltd.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2025 3.89x CN¥96.77 Million CN¥24.85 Million ▲ +310.4%
2024 0.95x CN¥70.94 Million CN¥74.76 Million ▲ +22.3%
2023 0.78x CN¥37.81 Million CN¥48.73 Million ▼ -80.3%
2018 3.93x CN¥38.44 Million CN¥9.77 Million ▲ +203.1%
2017 1.30x CN¥40.10 Million CN¥30.89 Million ▲ +17.1%
2016 1.11x CN¥41.65 Million CN¥37.56 Million ▲ +108.6%
2015 0.53x CN¥15.44 Million CN¥29.05 Million ▼ -63.9%
2014 1.47x CN¥82.19 Million CN¥55.89 Million ▼ -36.0%
2013 2.30x CN¥80.58 Million CN¥35.08 Million ▲ +116.5%
2012 1.06x CN¥35.05 Million CN¥33.04 Million ▲ +689.5%
2011 0.13x CN¥4.75 Million CN¥35.34 Million ▼ -87.6%
2010 1.08x CN¥52.03 Million CN¥47.98 Million ▼ -70.3%
2009 3.65x CN¥105.55 Million CN¥28.90 Million ▲ +221.6%
2008 -3.00x CN¥-39.16 Million CN¥13.04 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.